Exemestane
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00990 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | antithrombin deficiency type 2 | KG + DL |
| 2 | amenorrhea (disease) | KG + DL |
| 3 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 4 | heparin cofactor 2 deficiency | KG + DL |
| 5 | thrombophilia | KG + DL |
| 6 | migraine disorder | KG + DL |
| 7 | migraine with brainstem aura | KG + DL |
| 8 | acne (disease) | KG + DL |
| 9 | migraine with or without aura, susceptibility to | KG + DL |
| 10 | breast fibrocystic disease | KG + DL |
| 11 | benign mammary dysplasia | KG + DL |
| 12 | atrophoderma vermiculata | KG + DL |
| 13 | blunt duct adenosis of breast | KG + DL |
| 14 | apocrine adenosis of breast | KG + DL |
| 15 | ulerythema ophryogenesis | KG + DL |
| 16 | breast abscess | KG + DL |
| 17 | fat necrosis of breast | KG + DL |
| 18 | lactation disease | KG + DL |
| 19 | breast adenosis | KG + DL |
| 20 | infectious bovine rhinotracheitis | KG + DL |
| 21 | malignant catarrh | KG + DL |
| 22 | hypoalphalipoproteinemia | KG + DL |
| 23 | cytomegalovirus infection | KG + DL |
| 24 | kyphoscoliotic heart disease | KG + DL |
| 25 | sciatic neuropathy | KG + DL |
| 26 | pulmonary hypertension | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.